Patients & clinicians
Baxtra does not yet market any medicine. What we can offer today is clear information about our trials, our cleared device, and how to reach a human being here.
Considering a trial
What our studies involve, who they are for, and how to check whether you are eligible.
Find a studyUnderstanding your condition
Plain-language background on the four diseases we work on, written with clinicians.
Therapeutic areasCaregivers
Practical guidance for family members supporting someone taking part in research, including travel and time commitment.
Ask us a questionPatient support
We have no marketed medicine, so we have no co-pay program — but taking part in research should never leave a participant out of pocket. For every Baxtra-sponsored study we cover:
- All study medicine, devices and study-related procedures, at no cost
- Travel, parking and, where visits require it, overnight accommodation
- A stipend for time and inconvenience, set by the ethics committee
- A dedicated study coordinator you can call directly
- Continued access after the study for participants who are benefiting
When our first medicine reaches approval, our access and pricing plan will be published before launch rather than after it.
Talk to us
A real person answers these, usually the same day.
Trial questions
trials@baxtra.com · +1 (561) 555-0177
Medical information
medinfo@baxtra.com · +1 (561) 555-0119
Safety reporting
safety@baxtra.com · +1 (561) 555-0142
Report a side effect or device problem
You may also report directly to the FDA through MedWatch. Reporting to Baxtra does not replace reporting to the FDA.
For healthcare professionals
Scientific and technical resources intended for licensed clinicians.
Lumavue™ instructions for use
Full labelling, indications, contraindications, warnings and setup guidance for the cleared imaging system.
Device informationMedical information
Submit an unsolicited scientific question about any Baxtra program; answers are evidence-based and referenced.
Ask medical informationBecome a study site
We are actively adding sites for our Phase 1 programs and the Lumavue post-market study.
Site enquiriesSurgeon simulation lab
Hands-on sessions with our prototypes at the Palm Beach Gardens facility, open to practising surgeons.
Request a sessionInvestigator-initiated studies
Apply for support for research you design and sponsor.
Submit a conceptExpanded access
Our policy on providing investigational products outside a clinical trial.
Read the policyExpanded access (compassionate use)
In limited circumstances a physician may request an investigational Baxtra medicine for a patient with a serious or life-threatening condition who cannot enrol in a trial and has no satisfactory alternative. Requests must come from the treating physician.
What we consider
Whether the available data suggests potential benefit outweighs risk for that patient; whether supply exists; and whether providing the product would compromise the trials needed for approval. With only Phase 1 data on most programs, that third question is currently a real constraint and we will say so plainly.
How to request
The treating physician emails expandedaccess@baxtra.com. We acknowledge within two business days and aim to decide within ten.
Cost
Baxtra does not charge for investigational product supplied under expanded access.